Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Eisai to Establish European Strategic Hub in the UK
February 6, 2006
- Lead Chemical, Sankyo Announce Approval of Loxonin Poultice
February 6, 2006
- Takeda's Future Depends on Its Drug Discovery Research: Mr Takeda
February 6, 2006
- Obsessive Compulsive Disorders Approved as New Indication for Paxil: GSK
February 6, 2006
- Toyama to Give Domestic Marketing Rights for T-3811 to Astellas
February 6, 2006
- Contraindication of Paxil Lifted
February 6, 2006
- Meiji Seika to Establish Specialist MRs for GE Drug Business
February 6, 2006
- Study Group Approves 2nd Report on IRBs
February 6, 2006
- Sumitomo, Summit Medi-Chem to Invest in Medisa Shinyaku: Sawai
February 6, 2006
- Korosho Notifies Prefectures on How to Purchase, Stock Tamiflu
February 6, 2006
- BUSINESS NEWS IN BRIEF
February 6, 2006
- REGULATORY NEWS IN BRIEF
February 6, 2006
- Focus on Pollinosis (1)
February 6, 2006
- NEW PRODUCTS
February 6, 2006
- New JP-listed Drugs to Receive Same Exceptional Price Cut as Non-listed Drugs
February 6, 2006
- OPINION
February 6, 2006
- Foreign Price Adjustment Rule to Be Toughened
February 6, 2006
- JPMA Announces GL on Licensing of Patents on Research Tools
February 6, 2006
- 21 New Drugs Approved
February 6, 2006
- R&D NEWS IN BRIEF
February 6, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…